Sign In
Buy ALT
$2.92
+0.0500 (+1.74%)
At Close: Jun 04, 2026
Lost Money on Altimmune, Inc. (ALT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
05:15am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit
05:00am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc.
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
08:01pm, Thursday, 27'th Jun 2024
BENSALEM, Pa. , June 27, 2024 /PRNewswire/ -- Law Offices of Howard G.
3 Biotech Stocks For The Second Half Of 2024
04:48pm, Thursday, 27'th Jun 2024
3 Biotech Stocks For The Second Half Of 2024
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
07:35am, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
July 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
07:30am, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of Altimmune, Inc. (NASDAQ:ALT)? Did you purchase your shares between December 1, 2023 and April 26,
Investors in Altimmune, Inc. Should Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT
05:25am, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
Contact Levi & Korsinsky by July 5, 2024 Deadline to Join Class Action Against Altimmune, Inc.(ALT)
05:20am, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
IMMINENT ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit!
05:00am, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc.
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALT
12:30pm, Wednesday, 26'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 5, 2024 - ALT
12:30pm, Wednesday, 26'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 26, 2024 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follo
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)
12:06pm, Wednesday, 26'th Jun 2024
LOS ANGELES, June 26, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 5, 2024 deadline to file a lead plaintiff motion in the class action file
